Literature DB >> 16769371

Treatment to prevent patency of the ductus arteriosus: beneficial or harmful?

Carl L Bose, Matthew Laughon.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16769371     DOI: 10.1016/j.jpeds.2006.03.015

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  13 in total

1.  Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Authors:  Ronald I Clyman; Melissa Liebowitz
Journal:  J Pediatr       Date:  2017-07-11       Impact factor: 4.406

2.  Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all?

Authors:  Peter Gal
Journal:  J Pediatr Pharmacol Ther       Date:  2009-01

3.  Indomethacin vs ibuprofen: comparison of efficacy in the setting of conservative therapeutic approach.

Authors:  Andra Malikiwi; Charlene Roufaeil; Kenneth Tan; Arvind Sehgal
Journal:  Eur J Pediatr       Date:  2014-10-26       Impact factor: 3.183

4.  Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.

Authors:  Jonathan L Slaughter; Patricia B Reagan; Roopali V Bapat; Thomas B Newman; Mark A Klebanoff
Journal:  Eur J Pediatr       Date:  2016-02-15       Impact factor: 3.183

Review 5.  Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?

Authors:  Ronald I Clyman; James Couto; Gail M Murphy
Journal:  Semin Perinatol       Date:  2012-04       Impact factor: 3.300

6.  Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus.

Authors:  James I Hagadorn; Elizabeth A Brownell; Jennifer M Trzaski; Kendall R Johnson; Shabnam Lainwala; Brendan T Campbell; Katherine W Herbst
Journal:  Pediatr Res       Date:  2016-08-10       Impact factor: 3.756

7.  Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability.

Authors:  Christopher McPherson; Peter Gal; J Laurence Ransom; Rita Q Carlos; Mary Ann V T Dimaguila; McCrae Smith; Christie Davonzo; John E Wimmer
Journal:  Pediatr Cardiol       Date:  2010-01-10       Impact factor: 1.655

8.  Vocal fold paralysis following surgical ductal closure in extremely low birth weight infants: a case series of feeding and respiratory complications.

Authors:  W F Malcolm; C Hornik; A Evans; P B Smith; C M Cotten
Journal:  J Perinatol       Date:  2008-11       Impact factor: 2.521

Review 9.  Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?

Authors:  Vassilios Fanos; Michele Pusceddu; Angelica Dessì; Maria Antonietta Marcialis
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 10.  Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?

Authors:  P Vali; S Lakshminrusimha; A Pelech; M Underwood; F Ing
Journal:  J Perinatol       Date:  2019-09-27       Impact factor: 3.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.